Training Experience Required
- Proficient in written and spoken English.
- Eligible for GMC Full registration.
- At least one year post graduate training in medical or radiation oncology.
General Description
Oxford University Hospitals (OUH) is a world renowned centre of clinical excellence and one of the largest NHS teaching trusts in the UK.
The Trust is made up of four hospitals - the John Radcliffe Hospital (which includes the Children's Hospital, West Wing, Eye Hospital, Heart Centre and Women's Centre), the Churchill Hospital and the Nuffield Orthopaedic Centre, all located in Oxford, and the Horton General Hospital in Banbury, north Oxfordshire. The trust provides a wide range of clinical services, specialist services (including cardiac, cancer, musculoskeletal and neurological rehabilitation) medical education, training and research.
The collaboration with the University of Oxford underpins the quality of the care that is provided to patients, from the delivery of high-quality research, bringing innovation from the laboratory bench to the bedside, to the delivery of high-quality education and training of doctors. Existing collaborations include the ambitious research programmes established through the Oxford Biomedical Research Centre (BRC), funded by the National Institute for Health Research (NIHR), and the CRUK Oxford Cancer Centre. These set the standard in translating science and research into new and better NHS clinical care.
Expertise
The Early Phase Cancer Trials Unit (EPCTU) at the University of Oxford is a specialist, dedicated clinical trials unit, supporting early phase research integrating oncology and haematology as a seamless service. Recruiting over 150 patient per year, from a regional referral base of 10 million people, our key remit is the testing of novel therapies, on a bespoke 15 bedded ward incorporating a sample handling laboratory. Under the direction of our Principle Investigators, who are world-leading clinicians and clinician scientists, a team of research nurses and clinical fellows work across the broad portfolio of studies, providing expertise in patient management and protocol compliance.
In March 2009 the Department of Oncology at the Churchill Hospital moved into the new Oxford Cancer Centre. This £110 million project saw the relocation of services for both surgical and non-surgical oncology and haematology into the new build.
The (EPCTU) has an opportunity for a Clinical Research Fellow to work on the Early Phase Cancer Trials Unit at the University of Oxford. The post holder will be working alongside staff in the Oxford NIHR Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust and the University of Oxford. As part of the training programme the applicant will have the opportunity to undertake a clinical or translational research project at the Oxford Cancer Centre and pursue the University of Oxford MSc in Precision Cancer Medicine.
Facilitites
The University of Oxford medical sciences division hosts a large number of cancer research teams in major research institutes, ranging from epidemiology, public health, genomics, haematology, oncology, basic sciences, immunology, surgery, musculoskeletal sciences, histopathology and radiation. The Oxford Institute for Radiation Oncology (OIRO) opened on the Churchill site in 2008. In 2016, the radiotherapy department was designated an NCRI Established Centre of Excellence in Academic Radiation Oncology (currently only 3 in the UK). The University of Oxford Department of Oncology was formed in 2011, which brings together world-leading research teams in medical, radiation and surgical oncology. Professor Mark Middleton currently leads the Department, and Professor Amato Giaccia, the Oxford Institute. Many of the cancer research facilities of the University are based in research institutes across the University including the Weatherall Institute of Molecular Medicine, the Sir William Dunn School of Pathology and those on the Old Road Campus, adjacent to the Cancer Hospital. Co-located on the Campus are the Welcome Trust Centre for Human Genetics, the Ludwig Institute, the Jenner Institute for Vaccine Research, the Kennedy Institute for Rheumatology, the Institute for Biomedical Engineering and the Richard Doll Building for Epidemiology and Biostatistics. The Nuffield Department of Medicine Big Data centre and Target Discovery Institute are also on this site. Prof. Sarah Blagden leads the Oxford Clinical Trials Office (OCTO) as part of the OCTRU trials unit, that is also located within the cancer centre. Overall, the Cancer Research UK Oxford Centre provides training, infrastructure and core research funding and co-ordinates much of the University clinical cancer research portfolio. Finally, specific Early Breast Cancer Trialists Collaborative Group and population research is based in the Sir Richard Doll building and genetics of endocrine cancer groups are based in the Oxford Centre for Diabetes and Endocrinology.
Last update: September 2021
